Prediction of therapeutic microRNA based on the human metabolic network

Bioinformatics

Volumn 30, Issue 8, 2014, Pages 1163-1171

  Wu, Ming ^a   Chan, Christina ^a,b  

^a Michigan State University   (United States)

^b Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE COURSE; GENETICS; HUMAN; LIVER NEOPLASMS; METABOLISM;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS;

EID: 84898857127     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt751     Document Type: Article

References (73)

1. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
2. Becker, S.A. et al. (2007) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat. Protoc, 2, 727-738.
3. Becker, S.A. and Palsson, B.O. (2008) Context-specific metabolic networks are consistent with experiments. Plos Comput. Biol., 4, e1000082.
4. Calin, G.A. et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA, 99, 15524-15529.
5. Capello, M. et al. (2011) a-enolase: a promising therapeutic and diagnostic tumor target. FEBS J., 278, 1064-1074.
6. Caspi, R. et al. (2008) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res., 36, D623-D631.
7. Chan, C. et al. (2003) Metabolic flux analysis of cultured hepatocytes exposed to plasma. Biotechnol. Bioeng., 81, 33-49.
8. Chang, R.L. et al. (2010) Drug off-target effects predicted using structural analysis in the context of a metabolic network model. Plos Comput. Biol., 6, e1000938.
9. Christofk, H.R. et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature, 452, 230-233.
10. Colijn, C. et al. (2009) Interpreting expression data with metabolic flux models: predicting mycobacterium tuberculosis mycolic acid production. Plos Comput. Biol., 5, e1000489.
11. DeBerardinis, RJ. et al. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab., 7, 11-20.
12. Delgado, J. and Liao, J.C. (1997) Inverse flux analysis for reduction of acetate excretion in Escherichia coli. Biotechnol. Prog., 13, 361-367.
13. Duarte, N.C. et al. (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl Acad. Sci. USA, 104, 1777-1782.
14. Folger, O. et al. (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol., 7501.
15. Friedman, R.C. et al. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92-105.
16. Fritz, V. et al. (2010) Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol. Cancer Ther., 9, 1740-1754.
17. Galmarini, C.M. et al. (2008) Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. Curr. Med. Chem., 15, 1072-1082.
18. Gaur, A. et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res., 67, 2456-2468.
19. Gille, C. et al. (2010) HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol., 6, 411.
20. Hatziapostolou, M. et al. (2011) An HNF4a-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell, 147, 1233-1247.
21. He, L. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
22. Hess, D. et al. (2010) Inhibition of StearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. Plos One, 5, e11394.
23. Hiller, K. et al. (2011) Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. Curr. Pharm. Biotechnol., 12, 1075-1086.
24. Huang, S. and He, X. (2011) The role of microRNAs in liver cancer progression. Br. J. Cancer, 104, 235-240.
25. Igal, R.A. (2011) Roles of StearoylCoA desaturase-1 in the regulation of cancer cell growth, survival and tumorigenesis. Cancers, 3, 2462-2477.
26. Igal, R.A. (2010) Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis, 31, 1509-1515.
27. Jensen, P.A. and Papin, J.A. (2011) Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics, 27, 541-547.
28. Jerby, L. et al. (2010) Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol., 6, 401.
29. Johnson, S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
30. Koh, J.L.Y. et al. (2011) COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res., 40, D957-D963.
31. Kota, J. et al. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 137, 1005-1017.
32. Kumar, M.S. et al. (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet., 39, 673-677.
33. Kuo, T.Y. et al. (2012) Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence. Plos One, 7, e31587.
34. Lee, L. et al. (2011) Liverome: a curated database of liver cancer-related gene signatures with self-contained context information. BMC Genomics, 12, S3.
35. Li, W. et al. (2008) Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int. J. Cancer, 123, 1616-1622.
36. Liang, Y. (2008) An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med. Genomics, 1, 61.
37. Locasale, J.W. et al. (2011) Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet, 43, 869-874.
38. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
39. Mahadevan, R. and Schilling, C.H. (2003) The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng., 5, 264-276.
40. O'Donnell, K.A. et al. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
41. Orth, J.D. et al. (2010) What is flux balance analysis? Nat. Biotechnol., 28, 245-248.
42. Oulas, A. et al. (2011) Computational identification of miRNAs involved in cancer. Methods Mol. Biol., 676, 23-41.
43. Paolella, P. (1997) Introduction to Molecular Biology. 1st edn. McGraw-Hill Science/Engineering/Math, Boston, Mass.
44. Park, J.M. et al. (2009) Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol. Adv., 27, 979-988.
45. Patti, G.J. et al. (2012) Innovation: Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol., 13, 263-269.
46. Place, R.F. et al. (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA, 105, 1608-1613.
47. Pollari, S. et al. (2011) Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Treat., 125, 421-430.
48. Sassen, S. et al. (2008) MicroRNA-implications for cancer. Virchows Arch., 452, 1-10.
49. Schellenberger, J. et al. (2011) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc., 6, 1290-1307.
50. Serkova, N.J. et al. (2007) NMR-based metabolomics: translational application and treatment of cancer. Curr. Opin. Mol. Ther., 9, 572-585.
51. Shlomi, T. et al. (2008) Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol., 26, 1003-1010.
52. Shlomi, T. et al. (2011) Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg Effect. Plos Comput. Biol, 7, e1002018.
53. Singh, P.K. et al. (2011) Regulation of Aerobic Glycolysis by microRNAs in Cancer. Mol. Cell Pharmacol., 3, 125-134.
54. Sotgia, F. et al. (2012) Mitochondria 'fuel' breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle, 11, 4390-4401.
55. Srivastava, S. and Chan, C. (2008) Application of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line. Biotechnol. Bioeng., 99, 399-410.
56. Stephanopoulos, GN. et al. (1998) Metabolic Engineering: Principles and Methodologies. 1st edn. Academic Press, San Diego, California.
57. Toya, Y. et al. (2011) Metabolic flux analysis and visualization. J. Proteome Res., 10, 3313-3323.
58. Tsavachidou, D. et al. (2010) Glycogen metabolism provides nutritional support to renal cancer cells under conditions of stress and may serve as a marker of response to antiangiogenic therapy with bevacizumab. AACR Meet. Abstr., 2010, PR12.
59. Tsuda, N. et al. (2005) Synthetic microRNA and double-stranded RNA targeting the 3'-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells. Int. J. Oncol., 27, 1299-1306.
60. Tu, S.H. et al. (2010) Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast Cancer Res. Treat., 121, 539-553.
61. Van Berlo, RJ.P. et al. (2011) Predicting metabolic fluxes using gene expression differences as constraints. IEEE/ACM Trans. Comput. Biol. Bioinform., 8, 206-216.
62. Vander Heiden, M.G et al. (2012) Metabolic pathway alterations that support cell proliferation. Cold Spring Harb. Symp. Quant. Biol., 76, 325-334.
63. Vander Heiden, M.G. et al. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029-1033.
64. Wang, Y. et al. (2012) Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst. Biol., 6, 153.
65. WARBURG, O. (1956a) On respiratory impairment in cancer cells. Science, 124, 269-270.
66. WARBURG, O. (1956b) On the origin of cancer cells. Science, 123, 309-314.
67. Wu, M. and Chan, C. (2012) Human metabolic network: reconstruction, simulation, and applications in systems biology. Metabolites, 2, 242-253.
68. Xin, F. et al. (2009) Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics, 25, 430-434.
69. Xionghui Zhou et al. (2011) Context-specific miRNA regulation network predicts cancer prognosis. In: 2011 IEEE International Conference on Systems Biology (ISB). IEEE, New York, NY, pp. 225-243.
70. Ying, H. et al. (2012) Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell, 149, 656-670.
71. Zhang, S. et al. (2011) A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics, 27, i401-i409.
72. Zhang, Y. and Verbeek, F.J. (2010) Comparison and integration of target prediction algorithms for microRNA studies. J. Integr. Bioinform., 7, 3.
73. Zhou, Z. et al. (2012) Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity. Mol. Cell. Proteomics, 11, M111.011056.